Global Non Alcoholic Steatohepatitis Treatment Supply, Demand and Key Producers, 2023-2029
The global Non Alcoholic Steatohepatitis Treatment market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Non Alcoholic Steatohepatitis Treatment production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Non Alcoholic Steatohepatitis Treatment, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Non Alcoholic Steatohepatitis Treatment that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Non Alcoholic Steatohepatitis Treatment total production and demand, 2018-2029, (K Units)
Global Non Alcoholic Steatohepatitis Treatment total production value, 2018-2029, (USD Million)
Global Non Alcoholic Steatohepatitis Treatment production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Non Alcoholic Steatohepatitis Treatment consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Non Alcoholic Steatohepatitis Treatment domestic production, consumption, key domestic manufacturers and share
Global Non Alcoholic Steatohepatitis Treatment production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Non Alcoholic Steatohepatitis Treatment production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Non Alcoholic Steatohepatitis Treatment production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Non Alcoholic Steatohepatitis Treatment market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AstraZeneca Plc., Tobira Therapeutics Inc., Galmed Pharmaceuticals, Genfit SA, Zydus Cadila, Bristol Myers Squibb, Gilead Science, Conatus Pharmaceuticals Inc. and Novo Nordisk A/S, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Non Alcoholic Steatohepatitis Treatment market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Non Alcoholic Steatohepatitis Treatment Market, By Region:
1. How big is the global Non Alcoholic Steatohepatitis Treatment market?
2. What is the demand of the global Non Alcoholic Steatohepatitis Treatment market?
3. What is the year over year growth of the global Non Alcoholic Steatohepatitis Treatment market?
4. What is the production and production value of the global Non Alcoholic Steatohepatitis Treatment market?
5. Who are the key producers in the global Non Alcoholic Steatohepatitis Treatment market?
6. What are the growth factors driving the market demand?
This report studies the global Non Alcoholic Steatohepatitis Treatment production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Non Alcoholic Steatohepatitis Treatment, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Non Alcoholic Steatohepatitis Treatment that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Non Alcoholic Steatohepatitis Treatment total production and demand, 2018-2029, (K Units)
Global Non Alcoholic Steatohepatitis Treatment total production value, 2018-2029, (USD Million)
Global Non Alcoholic Steatohepatitis Treatment production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Non Alcoholic Steatohepatitis Treatment consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Non Alcoholic Steatohepatitis Treatment domestic production, consumption, key domestic manufacturers and share
Global Non Alcoholic Steatohepatitis Treatment production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Non Alcoholic Steatohepatitis Treatment production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Non Alcoholic Steatohepatitis Treatment production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Non Alcoholic Steatohepatitis Treatment market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AstraZeneca Plc., Tobira Therapeutics Inc., Galmed Pharmaceuticals, Genfit SA, Zydus Cadila, Bristol Myers Squibb, Gilead Science, Conatus Pharmaceuticals Inc. and Novo Nordisk A/S, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Non Alcoholic Steatohepatitis Treatment market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Non Alcoholic Steatohepatitis Treatment Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Vitamin E And Pioglitazone
- Ocaliva
- Elafibranor
- Obeticholic Acid
- Hospital Pharmacies
- Retail And Specialty Pharmacies
- AstraZeneca Plc.
- Tobira Therapeutics Inc.
- Galmed Pharmaceuticals
- Genfit SA
- Zydus Cadila
- Bristol Myers Squibb
- Gilead Science
- Conatus Pharmaceuticals Inc.
- Novo Nordisk A/S
- Immuron Ltd.
- Raptor Pharmaceutical Corporation
- Inventiva Pharma
- NGM Biopharmaceuticals Inc.
- Galectin Therapeutics Inc.
- Madrigal Pharmaceuticals
- Gemphire Therapeutics
1. How big is the global Non Alcoholic Steatohepatitis Treatment market?
2. What is the demand of the global Non Alcoholic Steatohepatitis Treatment market?
3. What is the year over year growth of the global Non Alcoholic Steatohepatitis Treatment market?
4. What is the production and production value of the global Non Alcoholic Steatohepatitis Treatment market?
5. Who are the key producers in the global Non Alcoholic Steatohepatitis Treatment market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Non Alcoholic Steatohepatitis Treatment Introduction
1.2 World Non Alcoholic Steatohepatitis Treatment Supply & Forecast
1.2.1 World Non Alcoholic Steatohepatitis Treatment Production Value (2018 & 2022 & 2029)
1.2.2 World Non Alcoholic Steatohepatitis Treatment Production (2018-2029)
1.2.3 World Non Alcoholic Steatohepatitis Treatment Pricing Trends (2018-2029)
1.3 World Non Alcoholic Steatohepatitis Treatment Production by Region (Based on Production Site)
1.3.1 World Non Alcoholic Steatohepatitis Treatment Production Value by Region (2018-2029)
1.3.2 World Non Alcoholic Steatohepatitis Treatment Production by Region (2018-2029)
1.3.3 World Non Alcoholic Steatohepatitis Treatment Average Price by Region (2018-2029)
1.3.4 North America Non Alcoholic Steatohepatitis Treatment Production (2018-2029)
1.3.5 Europe Non Alcoholic Steatohepatitis Treatment Production (2018-2029)
1.3.6 China Non Alcoholic Steatohepatitis Treatment Production (2018-2029)
1.3.7 Japan Non Alcoholic Steatohepatitis Treatment Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Non Alcoholic Steatohepatitis Treatment Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Non Alcoholic Steatohepatitis Treatment Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Non Alcoholic Steatohepatitis Treatment Demand (2018-2029)
2.2 World Non Alcoholic Steatohepatitis Treatment Consumption by Region
2.2.1 World Non Alcoholic Steatohepatitis Treatment Consumption by Region (2018-2023)
2.2.2 World Non Alcoholic Steatohepatitis Treatment Consumption Forecast by Region (2024-2029)
2.3 United States Non Alcoholic Steatohepatitis Treatment Consumption (2018-2029)
2.4 China Non Alcoholic Steatohepatitis Treatment Consumption (2018-2029)
2.5 Europe Non Alcoholic Steatohepatitis Treatment Consumption (2018-2029)
2.6 Japan Non Alcoholic Steatohepatitis Treatment Consumption (2018-2029)
2.7 South Korea Non Alcoholic Steatohepatitis Treatment Consumption (2018-2029)
2.8 ASEAN Non Alcoholic Steatohepatitis Treatment Consumption (2018-2029)
2.9 India Non Alcoholic Steatohepatitis Treatment Consumption (2018-2029)
3 WORLD NON ALCOHOLIC STEATOHEPATITIS TREATMENT MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Non Alcoholic Steatohepatitis Treatment Production Value by Manufacturer (2018-2023)
3.2 World Non Alcoholic Steatohepatitis Treatment Production by Manufacturer (2018-2023)
3.3 World Non Alcoholic Steatohepatitis Treatment Average Price by Manufacturer (2018-2023)
3.4 Non Alcoholic Steatohepatitis Treatment Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Non Alcoholic Steatohepatitis Treatment Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Non Alcoholic Steatohepatitis Treatment in 2022
3.5.3 Global Concentration Ratios (CR8) for Non Alcoholic Steatohepatitis Treatment in 2022
3.6 Non Alcoholic Steatohepatitis Treatment Market: Overall Company Footprint Analysis
3.6.1 Non Alcoholic Steatohepatitis Treatment Market: Region Footprint
3.6.2 Non Alcoholic Steatohepatitis Treatment Market: Company Product Type Footprint
3.6.3 Non Alcoholic Steatohepatitis Treatment Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Non Alcoholic Steatohepatitis Treatment Production Value Comparison
4.1.1 United States VS China: Non Alcoholic Steatohepatitis Treatment Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Non Alcoholic Steatohepatitis Treatment Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Non Alcoholic Steatohepatitis Treatment Production Comparison
4.2.1 United States VS China: Non Alcoholic Steatohepatitis Treatment Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Non Alcoholic Steatohepatitis Treatment Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Non Alcoholic Steatohepatitis Treatment Consumption Comparison
4.3.1 United States VS China: Non Alcoholic Steatohepatitis Treatment Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Non Alcoholic Steatohepatitis Treatment Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Non Alcoholic Steatohepatitis Treatment Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Non Alcoholic Steatohepatitis Treatment Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Non Alcoholic Steatohepatitis Treatment Production Value (2018-2023)
4.4.3 United States Based Manufacturers Non Alcoholic Steatohepatitis Treatment Production (2018-2023)
4.5 China Based Non Alcoholic Steatohepatitis Treatment Manufacturers and Market Share
4.5.1 China Based Non Alcoholic Steatohepatitis Treatment Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Non Alcoholic Steatohepatitis Treatment Production Value (2018-2023)
4.5.3 China Based Manufacturers Non Alcoholic Steatohepatitis Treatment Production (2018-2023)
4.6 Rest of World Based Non Alcoholic Steatohepatitis Treatment Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Non Alcoholic Steatohepatitis Treatment Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Non Alcoholic Steatohepatitis Treatment Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Non Alcoholic Steatohepatitis Treatment Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Non Alcoholic Steatohepatitis Treatment Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Vitamin E And Pioglitazone
5.2.2 Ocaliva
5.2.3 Elafibranor
5.2.4 Obeticholic Acid
5.3 Market Segment by Type
5.3.1 World Non Alcoholic Steatohepatitis Treatment Production by Type (2018-2029)
5.3.2 World Non Alcoholic Steatohepatitis Treatment Production Value by Type (2018-2029)
5.3.3 World Non Alcoholic Steatohepatitis Treatment Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Non Alcoholic Steatohepatitis Treatment Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital Pharmacies
6.2.2 Retail And Specialty Pharmacies
6.3 Market Segment by Application
6.3.1 World Non Alcoholic Steatohepatitis Treatment Production by Application (2018-2029)
6.3.2 World Non Alcoholic Steatohepatitis Treatment Production Value by Application (2018-2029)
6.3.3 World Non Alcoholic Steatohepatitis Treatment Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 AstraZeneca Plc.
7.1.1 AstraZeneca Plc. Details
7.1.2 AstraZeneca Plc. Major Business
7.1.3 AstraZeneca Plc. Non Alcoholic Steatohepatitis Treatment Product and Services
7.1.4 AstraZeneca Plc. Non Alcoholic Steatohepatitis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 AstraZeneca Plc. Recent Developments/Updates
7.1.6 AstraZeneca Plc. Competitive Strengths & Weaknesses
7.2 Tobira Therapeutics Inc.
7.2.1 Tobira Therapeutics Inc. Details
7.2.2 Tobira Therapeutics Inc. Major Business
7.2.3 Tobira Therapeutics Inc. Non Alcoholic Steatohepatitis Treatment Product and Services
7.2.4 Tobira Therapeutics Inc. Non Alcoholic Steatohepatitis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Tobira Therapeutics Inc. Recent Developments/Updates
7.2.6 Tobira Therapeutics Inc. Competitive Strengths & Weaknesses
7.3 Galmed Pharmaceuticals
7.3.1 Galmed Pharmaceuticals Details
7.3.2 Galmed Pharmaceuticals Major Business
7.3.3 Galmed Pharmaceuticals Non Alcoholic Steatohepatitis Treatment Product and Services
7.3.4 Galmed Pharmaceuticals Non Alcoholic Steatohepatitis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Galmed Pharmaceuticals Recent Developments/Updates
7.3.6 Galmed Pharmaceuticals Competitive Strengths & Weaknesses
7.4 Genfit SA
7.4.1 Genfit SA Details
7.4.2 Genfit SA Major Business
7.4.3 Genfit SA Non Alcoholic Steatohepatitis Treatment Product and Services
7.4.4 Genfit SA Non Alcoholic Steatohepatitis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Genfit SA Recent Developments/Updates
7.4.6 Genfit SA Competitive Strengths & Weaknesses
7.5 Zydus Cadila
7.5.1 Zydus Cadila Details
7.5.2 Zydus Cadila Major Business
7.5.3 Zydus Cadila Non Alcoholic Steatohepatitis Treatment Product and Services
7.5.4 Zydus Cadila Non Alcoholic Steatohepatitis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Zydus Cadila Recent Developments/Updates
7.5.6 Zydus Cadila Competitive Strengths & Weaknesses
7.6 Bristol Myers Squibb
7.6.1 Bristol Myers Squibb Details
7.6.2 Bristol Myers Squibb Major Business
7.6.3 Bristol Myers Squibb Non Alcoholic Steatohepatitis Treatment Product and Services
7.6.4 Bristol Myers Squibb Non Alcoholic Steatohepatitis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Bristol Myers Squibb Recent Developments/Updates
7.6.6 Bristol Myers Squibb Competitive Strengths & Weaknesses
7.7 Gilead Science
7.7.1 Gilead Science Details
7.7.2 Gilead Science Major Business
7.7.3 Gilead Science Non Alcoholic Steatohepatitis Treatment Product and Services
7.7.4 Gilead Science Non Alcoholic Steatohepatitis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Gilead Science Recent Developments/Updates
7.7.6 Gilead Science Competitive Strengths & Weaknesses
7.8 Conatus Pharmaceuticals Inc.
7.8.1 Conatus Pharmaceuticals Inc. Details
7.8.2 Conatus Pharmaceuticals Inc. Major Business
7.8.3 Conatus Pharmaceuticals Inc. Non Alcoholic Steatohepatitis Treatment Product and Services
7.8.4 Conatus Pharmaceuticals Inc. Non Alcoholic Steatohepatitis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Conatus Pharmaceuticals Inc. Recent Developments/Updates
7.8.6 Conatus Pharmaceuticals Inc. Competitive Strengths & Weaknesses
7.9 Novo Nordisk A/S
7.9.1 Novo Nordisk A/S Details
7.9.2 Novo Nordisk A/S Major Business
7.9.3 Novo Nordisk A/S Non Alcoholic Steatohepatitis Treatment Product and Services
7.9.4 Novo Nordisk A/S Non Alcoholic Steatohepatitis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Novo Nordisk A/S Recent Developments/Updates
7.9.6 Novo Nordisk A/S Competitive Strengths & Weaknesses
7.10 Immuron Ltd.
7.10.1 Immuron Ltd. Details
7.10.2 Immuron Ltd. Major Business
7.10.3 Immuron Ltd. Non Alcoholic Steatohepatitis Treatment Product and Services
7.10.4 Immuron Ltd. Non Alcoholic Steatohepatitis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Immuron Ltd. Recent Developments/Updates
7.10.6 Immuron Ltd. Competitive Strengths & Weaknesses
7.11 Raptor Pharmaceutical Corporation
7.11.1 Raptor Pharmaceutical Corporation Details
7.11.2 Raptor Pharmaceutical Corporation Major Business
7.11.3 Raptor Pharmaceutical Corporation Non Alcoholic Steatohepatitis Treatment Product and Services
7.11.4 Raptor Pharmaceutical Corporation Non Alcoholic Steatohepatitis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Raptor Pharmaceutical Corporation Recent Developments/Updates
7.11.6 Raptor Pharmaceutical Corporation Competitive Strengths & Weaknesses
7.12 Inventiva Pharma
7.12.1 Inventiva Pharma Details
7.12.2 Inventiva Pharma Major Business
7.12.3 Inventiva Pharma Non Alcoholic Steatohepatitis Treatment Product and Services
7.12.4 Inventiva Pharma Non Alcoholic Steatohepatitis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Inventiva Pharma Recent Developments/Updates
7.12.6 Inventiva Pharma Competitive Strengths & Weaknesses
7.13 NGM Biopharmaceuticals Inc.
7.13.1 NGM Biopharmaceuticals Inc. Details
7.13.2 NGM Biopharmaceuticals Inc. Major Business
7.13.3 NGM Biopharmaceuticals Inc. Non Alcoholic Steatohepatitis Treatment Product and Services
7.13.4 NGM Biopharmaceuticals Inc. Non Alcoholic Steatohepatitis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 NGM Biopharmaceuticals Inc. Recent Developments/Updates
7.13.6 NGM Biopharmaceuticals Inc. Competitive Strengths & Weaknesses
7.14 Galectin Therapeutics Inc.
7.14.1 Galectin Therapeutics Inc. Details
7.14.2 Galectin Therapeutics Inc. Major Business
7.14.3 Galectin Therapeutics Inc. Non Alcoholic Steatohepatitis Treatment Product and Services
7.14.4 Galectin Therapeutics Inc. Non Alcoholic Steatohepatitis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Galectin Therapeutics Inc. Recent Developments/Updates
7.14.6 Galectin Therapeutics Inc. Competitive Strengths & Weaknesses
7.15 Madrigal Pharmaceuticals
7.15.1 Madrigal Pharmaceuticals Details
7.15.2 Madrigal Pharmaceuticals Major Business
7.15.3 Madrigal Pharmaceuticals Non Alcoholic Steatohepatitis Treatment Product and Services
7.15.4 Madrigal Pharmaceuticals Non Alcoholic Steatohepatitis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Madrigal Pharmaceuticals Recent Developments/Updates
7.15.6 Madrigal Pharmaceuticals Competitive Strengths & Weaknesses
7.16 Gemphire Therapeutics
7.16.1 Gemphire Therapeutics Details
7.16.2 Gemphire Therapeutics Major Business
7.16.3 Gemphire Therapeutics Non Alcoholic Steatohepatitis Treatment Product and Services
7.16.4 Gemphire Therapeutics Non Alcoholic Steatohepatitis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Gemphire Therapeutics Recent Developments/Updates
7.16.6 Gemphire Therapeutics Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Non Alcoholic Steatohepatitis Treatment Industry Chain
8.2 Non Alcoholic Steatohepatitis Treatment Upstream Analysis
8.2.1 Non Alcoholic Steatohepatitis Treatment Core Raw Materials
8.2.2 Main Manufacturers of Non Alcoholic Steatohepatitis Treatment Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Non Alcoholic Steatohepatitis Treatment Production Mode
8.6 Non Alcoholic Steatohepatitis Treatment Procurement Model
8.7 Non Alcoholic Steatohepatitis Treatment Industry Sales Model and Sales Channels
8.7.1 Non Alcoholic Steatohepatitis Treatment Sales Model
8.7.2 Non Alcoholic Steatohepatitis Treatment Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Non Alcoholic Steatohepatitis Treatment Introduction
1.2 World Non Alcoholic Steatohepatitis Treatment Supply & Forecast
1.2.1 World Non Alcoholic Steatohepatitis Treatment Production Value (2018 & 2022 & 2029)
1.2.2 World Non Alcoholic Steatohepatitis Treatment Production (2018-2029)
1.2.3 World Non Alcoholic Steatohepatitis Treatment Pricing Trends (2018-2029)
1.3 World Non Alcoholic Steatohepatitis Treatment Production by Region (Based on Production Site)
1.3.1 World Non Alcoholic Steatohepatitis Treatment Production Value by Region (2018-2029)
1.3.2 World Non Alcoholic Steatohepatitis Treatment Production by Region (2018-2029)
1.3.3 World Non Alcoholic Steatohepatitis Treatment Average Price by Region (2018-2029)
1.3.4 North America Non Alcoholic Steatohepatitis Treatment Production (2018-2029)
1.3.5 Europe Non Alcoholic Steatohepatitis Treatment Production (2018-2029)
1.3.6 China Non Alcoholic Steatohepatitis Treatment Production (2018-2029)
1.3.7 Japan Non Alcoholic Steatohepatitis Treatment Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Non Alcoholic Steatohepatitis Treatment Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Non Alcoholic Steatohepatitis Treatment Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Non Alcoholic Steatohepatitis Treatment Demand (2018-2029)
2.2 World Non Alcoholic Steatohepatitis Treatment Consumption by Region
2.2.1 World Non Alcoholic Steatohepatitis Treatment Consumption by Region (2018-2023)
2.2.2 World Non Alcoholic Steatohepatitis Treatment Consumption Forecast by Region (2024-2029)
2.3 United States Non Alcoholic Steatohepatitis Treatment Consumption (2018-2029)
2.4 China Non Alcoholic Steatohepatitis Treatment Consumption (2018-2029)
2.5 Europe Non Alcoholic Steatohepatitis Treatment Consumption (2018-2029)
2.6 Japan Non Alcoholic Steatohepatitis Treatment Consumption (2018-2029)
2.7 South Korea Non Alcoholic Steatohepatitis Treatment Consumption (2018-2029)
2.8 ASEAN Non Alcoholic Steatohepatitis Treatment Consumption (2018-2029)
2.9 India Non Alcoholic Steatohepatitis Treatment Consumption (2018-2029)
3 WORLD NON ALCOHOLIC STEATOHEPATITIS TREATMENT MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Non Alcoholic Steatohepatitis Treatment Production Value by Manufacturer (2018-2023)
3.2 World Non Alcoholic Steatohepatitis Treatment Production by Manufacturer (2018-2023)
3.3 World Non Alcoholic Steatohepatitis Treatment Average Price by Manufacturer (2018-2023)
3.4 Non Alcoholic Steatohepatitis Treatment Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Non Alcoholic Steatohepatitis Treatment Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Non Alcoholic Steatohepatitis Treatment in 2022
3.5.3 Global Concentration Ratios (CR8) for Non Alcoholic Steatohepatitis Treatment in 2022
3.6 Non Alcoholic Steatohepatitis Treatment Market: Overall Company Footprint Analysis
3.6.1 Non Alcoholic Steatohepatitis Treatment Market: Region Footprint
3.6.2 Non Alcoholic Steatohepatitis Treatment Market: Company Product Type Footprint
3.6.3 Non Alcoholic Steatohepatitis Treatment Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Non Alcoholic Steatohepatitis Treatment Production Value Comparison
4.1.1 United States VS China: Non Alcoholic Steatohepatitis Treatment Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Non Alcoholic Steatohepatitis Treatment Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Non Alcoholic Steatohepatitis Treatment Production Comparison
4.2.1 United States VS China: Non Alcoholic Steatohepatitis Treatment Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Non Alcoholic Steatohepatitis Treatment Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Non Alcoholic Steatohepatitis Treatment Consumption Comparison
4.3.1 United States VS China: Non Alcoholic Steatohepatitis Treatment Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Non Alcoholic Steatohepatitis Treatment Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Non Alcoholic Steatohepatitis Treatment Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Non Alcoholic Steatohepatitis Treatment Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Non Alcoholic Steatohepatitis Treatment Production Value (2018-2023)
4.4.3 United States Based Manufacturers Non Alcoholic Steatohepatitis Treatment Production (2018-2023)
4.5 China Based Non Alcoholic Steatohepatitis Treatment Manufacturers and Market Share
4.5.1 China Based Non Alcoholic Steatohepatitis Treatment Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Non Alcoholic Steatohepatitis Treatment Production Value (2018-2023)
4.5.3 China Based Manufacturers Non Alcoholic Steatohepatitis Treatment Production (2018-2023)
4.6 Rest of World Based Non Alcoholic Steatohepatitis Treatment Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Non Alcoholic Steatohepatitis Treatment Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Non Alcoholic Steatohepatitis Treatment Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Non Alcoholic Steatohepatitis Treatment Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Non Alcoholic Steatohepatitis Treatment Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Vitamin E And Pioglitazone
5.2.2 Ocaliva
5.2.3 Elafibranor
5.2.4 Obeticholic Acid
5.3 Market Segment by Type
5.3.1 World Non Alcoholic Steatohepatitis Treatment Production by Type (2018-2029)
5.3.2 World Non Alcoholic Steatohepatitis Treatment Production Value by Type (2018-2029)
5.3.3 World Non Alcoholic Steatohepatitis Treatment Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Non Alcoholic Steatohepatitis Treatment Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital Pharmacies
6.2.2 Retail And Specialty Pharmacies
6.3 Market Segment by Application
6.3.1 World Non Alcoholic Steatohepatitis Treatment Production by Application (2018-2029)
6.3.2 World Non Alcoholic Steatohepatitis Treatment Production Value by Application (2018-2029)
6.3.3 World Non Alcoholic Steatohepatitis Treatment Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 AstraZeneca Plc.
7.1.1 AstraZeneca Plc. Details
7.1.2 AstraZeneca Plc. Major Business
7.1.3 AstraZeneca Plc. Non Alcoholic Steatohepatitis Treatment Product and Services
7.1.4 AstraZeneca Plc. Non Alcoholic Steatohepatitis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 AstraZeneca Plc. Recent Developments/Updates
7.1.6 AstraZeneca Plc. Competitive Strengths & Weaknesses
7.2 Tobira Therapeutics Inc.
7.2.1 Tobira Therapeutics Inc. Details
7.2.2 Tobira Therapeutics Inc. Major Business
7.2.3 Tobira Therapeutics Inc. Non Alcoholic Steatohepatitis Treatment Product and Services
7.2.4 Tobira Therapeutics Inc. Non Alcoholic Steatohepatitis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Tobira Therapeutics Inc. Recent Developments/Updates
7.2.6 Tobira Therapeutics Inc. Competitive Strengths & Weaknesses
7.3 Galmed Pharmaceuticals
7.3.1 Galmed Pharmaceuticals Details
7.3.2 Galmed Pharmaceuticals Major Business
7.3.3 Galmed Pharmaceuticals Non Alcoholic Steatohepatitis Treatment Product and Services
7.3.4 Galmed Pharmaceuticals Non Alcoholic Steatohepatitis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Galmed Pharmaceuticals Recent Developments/Updates
7.3.6 Galmed Pharmaceuticals Competitive Strengths & Weaknesses
7.4 Genfit SA
7.4.1 Genfit SA Details
7.4.2 Genfit SA Major Business
7.4.3 Genfit SA Non Alcoholic Steatohepatitis Treatment Product and Services
7.4.4 Genfit SA Non Alcoholic Steatohepatitis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Genfit SA Recent Developments/Updates
7.4.6 Genfit SA Competitive Strengths & Weaknesses
7.5 Zydus Cadila
7.5.1 Zydus Cadila Details
7.5.2 Zydus Cadila Major Business
7.5.3 Zydus Cadila Non Alcoholic Steatohepatitis Treatment Product and Services
7.5.4 Zydus Cadila Non Alcoholic Steatohepatitis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Zydus Cadila Recent Developments/Updates
7.5.6 Zydus Cadila Competitive Strengths & Weaknesses
7.6 Bristol Myers Squibb
7.6.1 Bristol Myers Squibb Details
7.6.2 Bristol Myers Squibb Major Business
7.6.3 Bristol Myers Squibb Non Alcoholic Steatohepatitis Treatment Product and Services
7.6.4 Bristol Myers Squibb Non Alcoholic Steatohepatitis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Bristol Myers Squibb Recent Developments/Updates
7.6.6 Bristol Myers Squibb Competitive Strengths & Weaknesses
7.7 Gilead Science
7.7.1 Gilead Science Details
7.7.2 Gilead Science Major Business
7.7.3 Gilead Science Non Alcoholic Steatohepatitis Treatment Product and Services
7.7.4 Gilead Science Non Alcoholic Steatohepatitis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Gilead Science Recent Developments/Updates
7.7.6 Gilead Science Competitive Strengths & Weaknesses
7.8 Conatus Pharmaceuticals Inc.
7.8.1 Conatus Pharmaceuticals Inc. Details
7.8.2 Conatus Pharmaceuticals Inc. Major Business
7.8.3 Conatus Pharmaceuticals Inc. Non Alcoholic Steatohepatitis Treatment Product and Services
7.8.4 Conatus Pharmaceuticals Inc. Non Alcoholic Steatohepatitis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Conatus Pharmaceuticals Inc. Recent Developments/Updates
7.8.6 Conatus Pharmaceuticals Inc. Competitive Strengths & Weaknesses
7.9 Novo Nordisk A/S
7.9.1 Novo Nordisk A/S Details
7.9.2 Novo Nordisk A/S Major Business
7.9.3 Novo Nordisk A/S Non Alcoholic Steatohepatitis Treatment Product and Services
7.9.4 Novo Nordisk A/S Non Alcoholic Steatohepatitis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Novo Nordisk A/S Recent Developments/Updates
7.9.6 Novo Nordisk A/S Competitive Strengths & Weaknesses
7.10 Immuron Ltd.
7.10.1 Immuron Ltd. Details
7.10.2 Immuron Ltd. Major Business
7.10.3 Immuron Ltd. Non Alcoholic Steatohepatitis Treatment Product and Services
7.10.4 Immuron Ltd. Non Alcoholic Steatohepatitis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Immuron Ltd. Recent Developments/Updates
7.10.6 Immuron Ltd. Competitive Strengths & Weaknesses
7.11 Raptor Pharmaceutical Corporation
7.11.1 Raptor Pharmaceutical Corporation Details
7.11.2 Raptor Pharmaceutical Corporation Major Business
7.11.3 Raptor Pharmaceutical Corporation Non Alcoholic Steatohepatitis Treatment Product and Services
7.11.4 Raptor Pharmaceutical Corporation Non Alcoholic Steatohepatitis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Raptor Pharmaceutical Corporation Recent Developments/Updates
7.11.6 Raptor Pharmaceutical Corporation Competitive Strengths & Weaknesses
7.12 Inventiva Pharma
7.12.1 Inventiva Pharma Details
7.12.2 Inventiva Pharma Major Business
7.12.3 Inventiva Pharma Non Alcoholic Steatohepatitis Treatment Product and Services
7.12.4 Inventiva Pharma Non Alcoholic Steatohepatitis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Inventiva Pharma Recent Developments/Updates
7.12.6 Inventiva Pharma Competitive Strengths & Weaknesses
7.13 NGM Biopharmaceuticals Inc.
7.13.1 NGM Biopharmaceuticals Inc. Details
7.13.2 NGM Biopharmaceuticals Inc. Major Business
7.13.3 NGM Biopharmaceuticals Inc. Non Alcoholic Steatohepatitis Treatment Product and Services
7.13.4 NGM Biopharmaceuticals Inc. Non Alcoholic Steatohepatitis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 NGM Biopharmaceuticals Inc. Recent Developments/Updates
7.13.6 NGM Biopharmaceuticals Inc. Competitive Strengths & Weaknesses
7.14 Galectin Therapeutics Inc.
7.14.1 Galectin Therapeutics Inc. Details
7.14.2 Galectin Therapeutics Inc. Major Business
7.14.3 Galectin Therapeutics Inc. Non Alcoholic Steatohepatitis Treatment Product and Services
7.14.4 Galectin Therapeutics Inc. Non Alcoholic Steatohepatitis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Galectin Therapeutics Inc. Recent Developments/Updates
7.14.6 Galectin Therapeutics Inc. Competitive Strengths & Weaknesses
7.15 Madrigal Pharmaceuticals
7.15.1 Madrigal Pharmaceuticals Details
7.15.2 Madrigal Pharmaceuticals Major Business
7.15.3 Madrigal Pharmaceuticals Non Alcoholic Steatohepatitis Treatment Product and Services
7.15.4 Madrigal Pharmaceuticals Non Alcoholic Steatohepatitis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Madrigal Pharmaceuticals Recent Developments/Updates
7.15.6 Madrigal Pharmaceuticals Competitive Strengths & Weaknesses
7.16 Gemphire Therapeutics
7.16.1 Gemphire Therapeutics Details
7.16.2 Gemphire Therapeutics Major Business
7.16.3 Gemphire Therapeutics Non Alcoholic Steatohepatitis Treatment Product and Services
7.16.4 Gemphire Therapeutics Non Alcoholic Steatohepatitis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Gemphire Therapeutics Recent Developments/Updates
7.16.6 Gemphire Therapeutics Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Non Alcoholic Steatohepatitis Treatment Industry Chain
8.2 Non Alcoholic Steatohepatitis Treatment Upstream Analysis
8.2.1 Non Alcoholic Steatohepatitis Treatment Core Raw Materials
8.2.2 Main Manufacturers of Non Alcoholic Steatohepatitis Treatment Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Non Alcoholic Steatohepatitis Treatment Production Mode
8.6 Non Alcoholic Steatohepatitis Treatment Procurement Model
8.7 Non Alcoholic Steatohepatitis Treatment Industry Sales Model and Sales Channels
8.7.1 Non Alcoholic Steatohepatitis Treatment Sales Model
8.7.2 Non Alcoholic Steatohepatitis Treatment Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Non Alcoholic Steatohepatitis Treatment Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Non Alcoholic Steatohepatitis Treatment Production Value by Region (2018-2023) & (USD Million)
Table 3. World Non Alcoholic Steatohepatitis Treatment Production Value by Region (2024-2029) & (USD Million)
Table 4. World Non Alcoholic Steatohepatitis Treatment Production Value Market Share by Region (2018-2023)
Table 5. World Non Alcoholic Steatohepatitis Treatment Production Value Market Share by Region (2024-2029)
Table 6. World Non Alcoholic Steatohepatitis Treatment Production by Region (2018-2023) & (K Units)
Table 7. World Non Alcoholic Steatohepatitis Treatment Production by Region (2024-2029) & (K Units)
Table 8. World Non Alcoholic Steatohepatitis Treatment Production Market Share by Region (2018-2023)
Table 9. World Non Alcoholic Steatohepatitis Treatment Production Market Share by Region (2024-2029)
Table 10. World Non Alcoholic Steatohepatitis Treatment Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Non Alcoholic Steatohepatitis Treatment Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Non Alcoholic Steatohepatitis Treatment Major Market Trends
Table 13. World Non Alcoholic Steatohepatitis Treatment Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Non Alcoholic Steatohepatitis Treatment Consumption by Region (2018-2023) & (K Units)
Table 15. World Non Alcoholic Steatohepatitis Treatment Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Non Alcoholic Steatohepatitis Treatment Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Non Alcoholic Steatohepatitis Treatment Producers in 2022
Table 18. World Non Alcoholic Steatohepatitis Treatment Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Non Alcoholic Steatohepatitis Treatment Producers in 2022
Table 20. World Non Alcoholic Steatohepatitis Treatment Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Non Alcoholic Steatohepatitis Treatment Company Evaluation Quadrant
Table 22. World Non Alcoholic Steatohepatitis Treatment Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Non Alcoholic Steatohepatitis Treatment Production Site of Key Manufacturer
Table 24. Non Alcoholic Steatohepatitis Treatment Market: Company Product Type Footprint
Table 25. Non Alcoholic Steatohepatitis Treatment Market: Company Product Application Footprint
Table 26. Non Alcoholic Steatohepatitis Treatment Competitive Factors
Table 27. Non Alcoholic Steatohepatitis Treatment New Entrant and Capacity Expansion Plans
Table 28. Non Alcoholic Steatohepatitis Treatment Mergers & Acquisitions Activity
Table 29. United States VS China Non Alcoholic Steatohepatitis Treatment Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Non Alcoholic Steatohepatitis Treatment Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Non Alcoholic Steatohepatitis Treatment Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Non Alcoholic Steatohepatitis Treatment Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Non Alcoholic Steatohepatitis Treatment Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Non Alcoholic Steatohepatitis Treatment Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Non Alcoholic Steatohepatitis Treatment Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Non Alcoholic Steatohepatitis Treatment Production Market Share (2018-2023)
Table 37. China Based Non Alcoholic Steatohepatitis Treatment Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Non Alcoholic Steatohepatitis Treatment Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Non Alcoholic Steatohepatitis Treatment Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Non Alcoholic Steatohepatitis Treatment Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Non Alcoholic Steatohepatitis Treatment Production Market Share (2018-2023)
Table 42. Rest of World Based Non Alcoholic Steatohepatitis Treatment Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Non Alcoholic Steatohepatitis Treatment Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Non Alcoholic Steatohepatitis Treatment Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Non Alcoholic Steatohepatitis Treatment Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Non Alcoholic Steatohepatitis Treatment Production Market Share (2018-2023)
Table 47. World Non Alcoholic Steatohepatitis Treatment Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Non Alcoholic Steatohepatitis Treatment Production by Type (2018-2023) & (K Units)
Table 49. World Non Alcoholic Steatohepatitis Treatment Production by Type (2024-2029) & (K Units)
Table 50. World Non Alcoholic Steatohepatitis Treatment Production Value by Type (2018-2023) & (USD Million)
Table 51. World Non Alcoholic Steatohepatitis Treatment Production Value by Type (2024-2029) & (USD Million)
Table 52. World Non Alcoholic Steatohepatitis Treatment Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Non Alcoholic Steatohepatitis Treatment Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Non Alcoholic Steatohepatitis Treatment Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Non Alcoholic Steatohepatitis Treatment Production by Application (2018-2023) & (K Units)
Table 56. World Non Alcoholic Steatohepatitis Treatment Production by Application (2024-2029) & (K Units)
Table 57. World Non Alcoholic Steatohepatitis Treatment Production Value by Application (2018-2023) & (USD Million)
Table 58. World Non Alcoholic Steatohepatitis Treatment Production Value by Application (2024-2029) & (USD Million)
Table 59. World Non Alcoholic Steatohepatitis Treatment Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Non Alcoholic Steatohepatitis Treatment Average Price by Application (2024-2029) & (US$/Unit)
Table 61. AstraZeneca Plc. Basic Information, Manufacturing Base and Competitors
Table 62. AstraZeneca Plc. Major Business
Table 63. AstraZeneca Plc. Non Alcoholic Steatohepatitis Treatment Product and Services
Table 64. AstraZeneca Plc. Non Alcoholic Steatohepatitis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. AstraZeneca Plc. Recent Developments/Updates
Table 66. AstraZeneca Plc. Competitive Strengths & Weaknesses
Table 67. Tobira Therapeutics Inc. Basic Information, Manufacturing Base and Competitors
Table 68. Tobira Therapeutics Inc. Major Business
Table 69. Tobira Therapeutics Inc. Non Alcoholic Steatohepatitis Treatment Product and Services
Table 70. Tobira Therapeutics Inc. Non Alcoholic Steatohepatitis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Tobira Therapeutics Inc. Recent Developments/Updates
Table 72. Tobira Therapeutics Inc. Competitive Strengths & Weaknesses
Table 73. Galmed Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 74. Galmed Pharmaceuticals Major Business
Table 75. Galmed Pharmaceuticals Non Alcoholic Steatohepatitis Treatment Product and Services
Table 76. Galmed Pharmaceuticals Non Alcoholic Steatohepatitis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Galmed Pharmaceuticals Recent Developments/Updates
Table 78. Galmed Pharmaceuticals Competitive Strengths & Weaknesses
Table 79. Genfit SA Basic Information, Manufacturing Base and Competitors
Table 80. Genfit SA Major Business
Table 81. Genfit SA Non Alcoholic Steatohepatitis Treatment Product and Services
Table 82. Genfit SA Non Alcoholic Steatohepatitis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Genfit SA Recent Developments/Updates
Table 84. Genfit SA Competitive Strengths & Weaknesses
Table 85. Zydus Cadila Basic Information, Manufacturing Base and Competitors
Table 86. Zydus Cadila Major Business
Table 87. Zydus Cadila Non Alcoholic Steatohepatitis Treatment Product and Services
Table 88. Zydus Cadila Non Alcoholic Steatohepatitis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Zydus Cadila Recent Developments/Updates
Table 90. Zydus Cadila Competitive Strengths & Weaknesses
Table 91. Bristol Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 92. Bristol Myers Squibb Major Business
Table 93. Bristol Myers Squibb Non Alcoholic Steatohepatitis Treatment Product and Services
Table 94. Bristol Myers Squibb Non Alcoholic Steatohepatitis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Bristol Myers Squibb Recent Developments/Updates
Table 96. Bristol Myers Squibb Competitive Strengths & Weaknesses
Table 97. Gilead Science Basic Information, Manufacturing Base and Competitors
Table 98. Gilead Science Major Business
Table 99. Gilead Science Non Alcoholic Steatohepatitis Treatment Product and Services
Table 100. Gilead Science Non Alcoholic Steatohepatitis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Gilead Science Recent Developments/Updates
Table 102. Gilead Science Competitive Strengths & Weaknesses
Table 103. Conatus Pharmaceuticals Inc. Basic Information, Manufacturing Base and Competitors
Table 104. Conatus Pharmaceuticals Inc. Major Business
Table 105. Conatus Pharmaceuticals Inc. Non Alcoholic Steatohepatitis Treatment Product and Services
Table 106. Conatus Pharmaceuticals Inc. Non Alcoholic Steatohepatitis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Conatus Pharmaceuticals Inc. Recent Developments/Updates
Table 108. Conatus Pharmaceuticals Inc. Competitive Strengths & Weaknesses
Table 109. Novo Nordisk A/S Basic Information, Manufacturing Base and Competitors
Table 110. Novo Nordisk A/S Major Business
Table 111. Novo Nordisk A/S Non Alcoholic Steatohepatitis Treatment Product and Services
Table 112. Novo Nordisk A/S Non Alcoholic Steatohepatitis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Novo Nordisk A/S Recent Developments/Updates
Table 114. Novo Nordisk A/S Competitive Strengths & Weaknesses
Table 115. Immuron Ltd. Basic Information, Manufacturing Base and Competitors
Table 116. Immuron Ltd. Major Business
Table 117. Immuron Ltd. Non Alcoholic Steatohepatitis Treatment Product and Services
Table 118. Immuron Ltd. Non Alcoholic Steatohepatitis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Immuron Ltd. Recent Developments/Updates
Table 120. Immuron Ltd. Competitive Strengths & Weaknesses
Table 121. Raptor Pharmaceutical Corporation Basic Information, Manufacturing Base and Competitors
Table 122. Raptor Pharmaceutical Corporation Major Business
Table 123. Raptor Pharmaceutical Corporation Non Alcoholic Steatohepatitis Treatment Product and Services
Table 124. Raptor Pharmaceutical Corporation Non Alcoholic Steatohepatitis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Raptor Pharmaceutical Corporation Recent Developments/Updates
Table 126. Raptor Pharmaceutical Corporation Competitive Strengths & Weaknesses
Table 127. Inventiva Pharma Basic Information, Manufacturing Base and Competitors
Table 128. Inventiva Pharma Major Business
Table 129. Inventiva Pharma Non Alcoholic Steatohepatitis Treatment Product and Services
Table 130. Inventiva Pharma Non Alcoholic Steatohepatitis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Inventiva Pharma Recent Developments/Updates
Table 132. Inventiva Pharma Competitive Strengths & Weaknesses
Table 133. NGM Biopharmaceuticals Inc. Basic Information, Manufacturing Base and Competitors
Table 134. NGM Biopharmaceuticals Inc. Major Business
Table 135. NGM Biopharmaceuticals Inc. Non Alcoholic Steatohepatitis Treatment Product and Services
Table 136. NGM Biopharmaceuticals Inc. Non Alcoholic Steatohepatitis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. NGM Biopharmaceuticals Inc. Recent Developments/Updates
Table 138. NGM Biopharmaceuticals Inc. Competitive Strengths & Weaknesses
Table 139. Galectin Therapeutics Inc. Basic Information, Manufacturing Base and Competitors
Table 140. Galectin Therapeutics Inc. Major Business
Table 141. Galectin Therapeutics Inc. Non Alcoholic Steatohepatitis Treatment Product and Services
Table 142. Galectin Therapeutics Inc. Non Alcoholic Steatohepatitis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Galectin Therapeutics Inc. Recent Developments/Updates
Table 144. Galectin Therapeutics Inc. Competitive Strengths & Weaknesses
Table 145. Madrigal Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 146. Madrigal Pharmaceuticals Major Business
Table 147. Madrigal Pharmaceuticals Non Alcoholic Steatohepatitis Treatment Product and Services
Table 148. Madrigal Pharmaceuticals Non Alcoholic Steatohepatitis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Madrigal Pharmaceuticals Recent Developments/Updates
Table 150. Gemphire Therapeutics Basic Information, Manufacturing Base and Competitors
Table 151. Gemphire Therapeutics Major Business
Table 152. Gemphire Therapeutics Non Alcoholic Steatohepatitis Treatment Product and Services
Table 153. Gemphire Therapeutics Non Alcoholic Steatohepatitis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 154. Global Key Players of Non Alcoholic Steatohepatitis Treatment Upstream (Raw Materials)
Table 155. Non Alcoholic Steatohepatitis Treatment Typical Customers
Table 156. Non Alcoholic Steatohepatitis Treatment Typical Distributors
Table 1. World Non Alcoholic Steatohepatitis Treatment Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Non Alcoholic Steatohepatitis Treatment Production Value by Region (2018-2023) & (USD Million)
Table 3. World Non Alcoholic Steatohepatitis Treatment Production Value by Region (2024-2029) & (USD Million)
Table 4. World Non Alcoholic Steatohepatitis Treatment Production Value Market Share by Region (2018-2023)
Table 5. World Non Alcoholic Steatohepatitis Treatment Production Value Market Share by Region (2024-2029)
Table 6. World Non Alcoholic Steatohepatitis Treatment Production by Region (2018-2023) & (K Units)
Table 7. World Non Alcoholic Steatohepatitis Treatment Production by Region (2024-2029) & (K Units)
Table 8. World Non Alcoholic Steatohepatitis Treatment Production Market Share by Region (2018-2023)
Table 9. World Non Alcoholic Steatohepatitis Treatment Production Market Share by Region (2024-2029)
Table 10. World Non Alcoholic Steatohepatitis Treatment Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Non Alcoholic Steatohepatitis Treatment Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Non Alcoholic Steatohepatitis Treatment Major Market Trends
Table 13. World Non Alcoholic Steatohepatitis Treatment Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Non Alcoholic Steatohepatitis Treatment Consumption by Region (2018-2023) & (K Units)
Table 15. World Non Alcoholic Steatohepatitis Treatment Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Non Alcoholic Steatohepatitis Treatment Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Non Alcoholic Steatohepatitis Treatment Producers in 2022
Table 18. World Non Alcoholic Steatohepatitis Treatment Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Non Alcoholic Steatohepatitis Treatment Producers in 2022
Table 20. World Non Alcoholic Steatohepatitis Treatment Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Non Alcoholic Steatohepatitis Treatment Company Evaluation Quadrant
Table 22. World Non Alcoholic Steatohepatitis Treatment Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Non Alcoholic Steatohepatitis Treatment Production Site of Key Manufacturer
Table 24. Non Alcoholic Steatohepatitis Treatment Market: Company Product Type Footprint
Table 25. Non Alcoholic Steatohepatitis Treatment Market: Company Product Application Footprint
Table 26. Non Alcoholic Steatohepatitis Treatment Competitive Factors
Table 27. Non Alcoholic Steatohepatitis Treatment New Entrant and Capacity Expansion Plans
Table 28. Non Alcoholic Steatohepatitis Treatment Mergers & Acquisitions Activity
Table 29. United States VS China Non Alcoholic Steatohepatitis Treatment Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Non Alcoholic Steatohepatitis Treatment Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Non Alcoholic Steatohepatitis Treatment Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Non Alcoholic Steatohepatitis Treatment Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Non Alcoholic Steatohepatitis Treatment Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Non Alcoholic Steatohepatitis Treatment Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Non Alcoholic Steatohepatitis Treatment Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Non Alcoholic Steatohepatitis Treatment Production Market Share (2018-2023)
Table 37. China Based Non Alcoholic Steatohepatitis Treatment Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Non Alcoholic Steatohepatitis Treatment Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Non Alcoholic Steatohepatitis Treatment Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Non Alcoholic Steatohepatitis Treatment Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Non Alcoholic Steatohepatitis Treatment Production Market Share (2018-2023)
Table 42. Rest of World Based Non Alcoholic Steatohepatitis Treatment Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Non Alcoholic Steatohepatitis Treatment Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Non Alcoholic Steatohepatitis Treatment Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Non Alcoholic Steatohepatitis Treatment Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Non Alcoholic Steatohepatitis Treatment Production Market Share (2018-2023)
Table 47. World Non Alcoholic Steatohepatitis Treatment Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Non Alcoholic Steatohepatitis Treatment Production by Type (2018-2023) & (K Units)
Table 49. World Non Alcoholic Steatohepatitis Treatment Production by Type (2024-2029) & (K Units)
Table 50. World Non Alcoholic Steatohepatitis Treatment Production Value by Type (2018-2023) & (USD Million)
Table 51. World Non Alcoholic Steatohepatitis Treatment Production Value by Type (2024-2029) & (USD Million)
Table 52. World Non Alcoholic Steatohepatitis Treatment Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Non Alcoholic Steatohepatitis Treatment Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Non Alcoholic Steatohepatitis Treatment Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Non Alcoholic Steatohepatitis Treatment Production by Application (2018-2023) & (K Units)
Table 56. World Non Alcoholic Steatohepatitis Treatment Production by Application (2024-2029) & (K Units)
Table 57. World Non Alcoholic Steatohepatitis Treatment Production Value by Application (2018-2023) & (USD Million)
Table 58. World Non Alcoholic Steatohepatitis Treatment Production Value by Application (2024-2029) & (USD Million)
Table 59. World Non Alcoholic Steatohepatitis Treatment Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Non Alcoholic Steatohepatitis Treatment Average Price by Application (2024-2029) & (US$/Unit)
Table 61. AstraZeneca Plc. Basic Information, Manufacturing Base and Competitors
Table 62. AstraZeneca Plc. Major Business
Table 63. AstraZeneca Plc. Non Alcoholic Steatohepatitis Treatment Product and Services
Table 64. AstraZeneca Plc. Non Alcoholic Steatohepatitis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. AstraZeneca Plc. Recent Developments/Updates
Table 66. AstraZeneca Plc. Competitive Strengths & Weaknesses
Table 67. Tobira Therapeutics Inc. Basic Information, Manufacturing Base and Competitors
Table 68. Tobira Therapeutics Inc. Major Business
Table 69. Tobira Therapeutics Inc. Non Alcoholic Steatohepatitis Treatment Product and Services
Table 70. Tobira Therapeutics Inc. Non Alcoholic Steatohepatitis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Tobira Therapeutics Inc. Recent Developments/Updates
Table 72. Tobira Therapeutics Inc. Competitive Strengths & Weaknesses
Table 73. Galmed Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 74. Galmed Pharmaceuticals Major Business
Table 75. Galmed Pharmaceuticals Non Alcoholic Steatohepatitis Treatment Product and Services
Table 76. Galmed Pharmaceuticals Non Alcoholic Steatohepatitis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Galmed Pharmaceuticals Recent Developments/Updates
Table 78. Galmed Pharmaceuticals Competitive Strengths & Weaknesses
Table 79. Genfit SA Basic Information, Manufacturing Base and Competitors
Table 80. Genfit SA Major Business
Table 81. Genfit SA Non Alcoholic Steatohepatitis Treatment Product and Services
Table 82. Genfit SA Non Alcoholic Steatohepatitis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Genfit SA Recent Developments/Updates
Table 84. Genfit SA Competitive Strengths & Weaknesses
Table 85. Zydus Cadila Basic Information, Manufacturing Base and Competitors
Table 86. Zydus Cadila Major Business
Table 87. Zydus Cadila Non Alcoholic Steatohepatitis Treatment Product and Services
Table 88. Zydus Cadila Non Alcoholic Steatohepatitis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Zydus Cadila Recent Developments/Updates
Table 90. Zydus Cadila Competitive Strengths & Weaknesses
Table 91. Bristol Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 92. Bristol Myers Squibb Major Business
Table 93. Bristol Myers Squibb Non Alcoholic Steatohepatitis Treatment Product and Services
Table 94. Bristol Myers Squibb Non Alcoholic Steatohepatitis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Bristol Myers Squibb Recent Developments/Updates
Table 96. Bristol Myers Squibb Competitive Strengths & Weaknesses
Table 97. Gilead Science Basic Information, Manufacturing Base and Competitors
Table 98. Gilead Science Major Business
Table 99. Gilead Science Non Alcoholic Steatohepatitis Treatment Product and Services
Table 100. Gilead Science Non Alcoholic Steatohepatitis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Gilead Science Recent Developments/Updates
Table 102. Gilead Science Competitive Strengths & Weaknesses
Table 103. Conatus Pharmaceuticals Inc. Basic Information, Manufacturing Base and Competitors
Table 104. Conatus Pharmaceuticals Inc. Major Business
Table 105. Conatus Pharmaceuticals Inc. Non Alcoholic Steatohepatitis Treatment Product and Services
Table 106. Conatus Pharmaceuticals Inc. Non Alcoholic Steatohepatitis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Conatus Pharmaceuticals Inc. Recent Developments/Updates
Table 108. Conatus Pharmaceuticals Inc. Competitive Strengths & Weaknesses
Table 109. Novo Nordisk A/S Basic Information, Manufacturing Base and Competitors
Table 110. Novo Nordisk A/S Major Business
Table 111. Novo Nordisk A/S Non Alcoholic Steatohepatitis Treatment Product and Services
Table 112. Novo Nordisk A/S Non Alcoholic Steatohepatitis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Novo Nordisk A/S Recent Developments/Updates
Table 114. Novo Nordisk A/S Competitive Strengths & Weaknesses
Table 115. Immuron Ltd. Basic Information, Manufacturing Base and Competitors
Table 116. Immuron Ltd. Major Business
Table 117. Immuron Ltd. Non Alcoholic Steatohepatitis Treatment Product and Services
Table 118. Immuron Ltd. Non Alcoholic Steatohepatitis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Immuron Ltd. Recent Developments/Updates
Table 120. Immuron Ltd. Competitive Strengths & Weaknesses
Table 121. Raptor Pharmaceutical Corporation Basic Information, Manufacturing Base and Competitors
Table 122. Raptor Pharmaceutical Corporation Major Business
Table 123. Raptor Pharmaceutical Corporation Non Alcoholic Steatohepatitis Treatment Product and Services
Table 124. Raptor Pharmaceutical Corporation Non Alcoholic Steatohepatitis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Raptor Pharmaceutical Corporation Recent Developments/Updates
Table 126. Raptor Pharmaceutical Corporation Competitive Strengths & Weaknesses
Table 127. Inventiva Pharma Basic Information, Manufacturing Base and Competitors
Table 128. Inventiva Pharma Major Business
Table 129. Inventiva Pharma Non Alcoholic Steatohepatitis Treatment Product and Services
Table 130. Inventiva Pharma Non Alcoholic Steatohepatitis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Inventiva Pharma Recent Developments/Updates
Table 132. Inventiva Pharma Competitive Strengths & Weaknesses
Table 133. NGM Biopharmaceuticals Inc. Basic Information, Manufacturing Base and Competitors
Table 134. NGM Biopharmaceuticals Inc. Major Business
Table 135. NGM Biopharmaceuticals Inc. Non Alcoholic Steatohepatitis Treatment Product and Services
Table 136. NGM Biopharmaceuticals Inc. Non Alcoholic Steatohepatitis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. NGM Biopharmaceuticals Inc. Recent Developments/Updates
Table 138. NGM Biopharmaceuticals Inc. Competitive Strengths & Weaknesses
Table 139. Galectin Therapeutics Inc. Basic Information, Manufacturing Base and Competitors
Table 140. Galectin Therapeutics Inc. Major Business
Table 141. Galectin Therapeutics Inc. Non Alcoholic Steatohepatitis Treatment Product and Services
Table 142. Galectin Therapeutics Inc. Non Alcoholic Steatohepatitis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Galectin Therapeutics Inc. Recent Developments/Updates
Table 144. Galectin Therapeutics Inc. Competitive Strengths & Weaknesses
Table 145. Madrigal Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 146. Madrigal Pharmaceuticals Major Business
Table 147. Madrigal Pharmaceuticals Non Alcoholic Steatohepatitis Treatment Product and Services
Table 148. Madrigal Pharmaceuticals Non Alcoholic Steatohepatitis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Madrigal Pharmaceuticals Recent Developments/Updates
Table 150. Gemphire Therapeutics Basic Information, Manufacturing Base and Competitors
Table 151. Gemphire Therapeutics Major Business
Table 152. Gemphire Therapeutics Non Alcoholic Steatohepatitis Treatment Product and Services
Table 153. Gemphire Therapeutics Non Alcoholic Steatohepatitis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 154. Global Key Players of Non Alcoholic Steatohepatitis Treatment Upstream (Raw Materials)
Table 155. Non Alcoholic Steatohepatitis Treatment Typical Customers
Table 156. Non Alcoholic Steatohepatitis Treatment Typical Distributors
LIST OF FIGURES
Figure 1. Non Alcoholic Steatohepatitis Treatment Picture
Figure 2. World Non Alcoholic Steatohepatitis Treatment Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Non Alcoholic Steatohepatitis Treatment Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Non Alcoholic Steatohepatitis Treatment Production (2018-2029) & (K Units)
Figure 5. World Non Alcoholic Steatohepatitis Treatment Average Price (2018-2029) & (US$/Unit)
Figure 6. World Non Alcoholic Steatohepatitis Treatment Production Value Market Share by Region (2018-2029)
Figure 7. World Non Alcoholic Steatohepatitis Treatment Production Market Share by Region (2018-2029)
Figure 8. North America Non Alcoholic Steatohepatitis Treatment Production (2018-2029) & (K Units)
Figure 9. Europe Non Alcoholic Steatohepatitis Treatment Production (2018-2029) & (K Units)
Figure 10. China Non Alcoholic Steatohepatitis Treatment Production (2018-2029) & (K Units)
Figure 11. Japan Non Alcoholic Steatohepatitis Treatment Production (2018-2029) & (K Units)
Figure 12. Non Alcoholic Steatohepatitis Treatment Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Non Alcoholic Steatohepatitis Treatment Consumption (2018-2029) & (K Units)
Figure 15. World Non Alcoholic Steatohepatitis Treatment Consumption Market Share by Region (2018-2029)
Figure 16. United States Non Alcoholic Steatohepatitis Treatment Consumption (2018-2029) & (K Units)
Figure 17. China Non Alcoholic Steatohepatitis Treatment Consumption (2018-2029) & (K Units)
Figure 18. Europe Non Alcoholic Steatohepatitis Treatment Consumption (2018-2029) & (K Units)
Figure 19. Japan Non Alcoholic Steatohepatitis Treatment Consumption (2018-2029) & (K Units)
Figure 20. South Korea Non Alcoholic Steatohepatitis Treatment Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Non Alcoholic Steatohepatitis Treatment Consumption (2018-2029) & (K Units)
Figure 22. India Non Alcoholic Steatohepatitis Treatment Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Non Alcoholic Steatohepatitis Treatment by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Non Alcoholic Steatohepatitis Treatment Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Non Alcoholic Steatohepatitis Treatment Markets in 2022
Figure 26. United States VS China: Non Alcoholic Steatohepatitis Treatment Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Non Alcoholic Steatohepatitis Treatment Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Non Alcoholic Steatohepatitis Treatment Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Non Alcoholic Steatohepatitis Treatment Production Market Share 2022
Figure 30. China Based Manufacturers Non Alcoholic Steatohepatitis Treatment Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Non Alcoholic Steatohepatitis Treatment Production Market Share 2022
Figure 32. World Non Alcoholic Steatohepatitis Treatment Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Non Alcoholic Steatohepatitis Treatment Production Value Market Share by Type in 2022
Figure 34. Vitamin E And Pioglitazone
Figure 35. Ocaliva
Figure 36. Elafibranor
Figure 37. Obeticholic Acid
Figure 38. World Non Alcoholic Steatohepatitis Treatment Production Market Share by Type (2018-2029)
Figure 39. World Non Alcoholic Steatohepatitis Treatment Production Value Market Share by Type (2018-2029)
Figure 40. World Non Alcoholic Steatohepatitis Treatment Average Price by Type (2018-2029) & (US$/Unit)
Figure 41. World Non Alcoholic Steatohepatitis Treatment Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 42. World Non Alcoholic Steatohepatitis Treatment Production Value Market Share by Application in 2022
Figure 43. Hospital Pharmacies
Figure 44. Retail And Specialty Pharmacies
Figure 45. World Non Alcoholic Steatohepatitis Treatment Production Market Share by Application (2018-2029)
Figure 46. World Non Alcoholic Steatohepatitis Treatment Production Value Market Share by Application (2018-2029)
Figure 47. World Non Alcoholic Steatohepatitis Treatment Average Price by Application (2018-2029) & (US$/Unit)
Figure 48. Non Alcoholic Steatohepatitis Treatment Industry Chain
Figure 49. Non Alcoholic Steatohepatitis Treatment Procurement Model
Figure 50. Non Alcoholic Steatohepatitis Treatment Sales Model
Figure 51. Non Alcoholic Steatohepatitis Treatment Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
Figure 1. Non Alcoholic Steatohepatitis Treatment Picture
Figure 2. World Non Alcoholic Steatohepatitis Treatment Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Non Alcoholic Steatohepatitis Treatment Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Non Alcoholic Steatohepatitis Treatment Production (2018-2029) & (K Units)
Figure 5. World Non Alcoholic Steatohepatitis Treatment Average Price (2018-2029) & (US$/Unit)
Figure 6. World Non Alcoholic Steatohepatitis Treatment Production Value Market Share by Region (2018-2029)
Figure 7. World Non Alcoholic Steatohepatitis Treatment Production Market Share by Region (2018-2029)
Figure 8. North America Non Alcoholic Steatohepatitis Treatment Production (2018-2029) & (K Units)
Figure 9. Europe Non Alcoholic Steatohepatitis Treatment Production (2018-2029) & (K Units)
Figure 10. China Non Alcoholic Steatohepatitis Treatment Production (2018-2029) & (K Units)
Figure 11. Japan Non Alcoholic Steatohepatitis Treatment Production (2018-2029) & (K Units)
Figure 12. Non Alcoholic Steatohepatitis Treatment Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Non Alcoholic Steatohepatitis Treatment Consumption (2018-2029) & (K Units)
Figure 15. World Non Alcoholic Steatohepatitis Treatment Consumption Market Share by Region (2018-2029)
Figure 16. United States Non Alcoholic Steatohepatitis Treatment Consumption (2018-2029) & (K Units)
Figure 17. China Non Alcoholic Steatohepatitis Treatment Consumption (2018-2029) & (K Units)
Figure 18. Europe Non Alcoholic Steatohepatitis Treatment Consumption (2018-2029) & (K Units)
Figure 19. Japan Non Alcoholic Steatohepatitis Treatment Consumption (2018-2029) & (K Units)
Figure 20. South Korea Non Alcoholic Steatohepatitis Treatment Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Non Alcoholic Steatohepatitis Treatment Consumption (2018-2029) & (K Units)
Figure 22. India Non Alcoholic Steatohepatitis Treatment Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Non Alcoholic Steatohepatitis Treatment by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Non Alcoholic Steatohepatitis Treatment Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Non Alcoholic Steatohepatitis Treatment Markets in 2022
Figure 26. United States VS China: Non Alcoholic Steatohepatitis Treatment Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Non Alcoholic Steatohepatitis Treatment Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Non Alcoholic Steatohepatitis Treatment Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Non Alcoholic Steatohepatitis Treatment Production Market Share 2022
Figure 30. China Based Manufacturers Non Alcoholic Steatohepatitis Treatment Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Non Alcoholic Steatohepatitis Treatment Production Market Share 2022
Figure 32. World Non Alcoholic Steatohepatitis Treatment Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Non Alcoholic Steatohepatitis Treatment Production Value Market Share by Type in 2022
Figure 34. Vitamin E And Pioglitazone
Figure 35. Ocaliva
Figure 36. Elafibranor
Figure 37. Obeticholic Acid
Figure 38. World Non Alcoholic Steatohepatitis Treatment Production Market Share by Type (2018-2029)
Figure 39. World Non Alcoholic Steatohepatitis Treatment Production Value Market Share by Type (2018-2029)
Figure 40. World Non Alcoholic Steatohepatitis Treatment Average Price by Type (2018-2029) & (US$/Unit)
Figure 41. World Non Alcoholic Steatohepatitis Treatment Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 42. World Non Alcoholic Steatohepatitis Treatment Production Value Market Share by Application in 2022
Figure 43. Hospital Pharmacies
Figure 44. Retail And Specialty Pharmacies
Figure 45. World Non Alcoholic Steatohepatitis Treatment Production Market Share by Application (2018-2029)
Figure 46. World Non Alcoholic Steatohepatitis Treatment Production Value Market Share by Application (2018-2029)
Figure 47. World Non Alcoholic Steatohepatitis Treatment Average Price by Application (2018-2029) & (US$/Unit)
Figure 48. Non Alcoholic Steatohepatitis Treatment Industry Chain
Figure 49. Non Alcoholic Steatohepatitis Treatment Procurement Model
Figure 50. Non Alcoholic Steatohepatitis Treatment Sales Model
Figure 51. Non Alcoholic Steatohepatitis Treatment Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
